海利生物
(603718)
| 流通市值：45.82亿 | | | 总市值：46.29亿 |
| 流通股本：6.49亿 | | | 总股本：6.56亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 309,982,581.63 | 353,232,083.01 | 362,243,931.99 | 358,503,504.83 |
| 交易性金融资产 | 160,284,310.31 | 162,588,615.35 | 113,551,968.15 | 158,580,711.43 |
| 应收票据及应收账款 | 110,195,662.82 | 105,463,747.81 | 126,856,127.76 | 108,965,294.39 |
| 其中：应收票据 | 2,390,863.52 | 2,047,095 | 1,743,295 | 543,195 |
| 应收账款 | 107,804,799.3 | 103,416,652.81 | 125,112,832.76 | 108,422,099.39 |
| 预付款项 | 4,127,443.61 | 3,710,075.19 | 3,665,987.23 | 2,818,692.69 |
| 其他应收款合计 | 5,509,526.44 | 2,812,954.06 | 3,048,359.18 | 2,924,158.3 |
| 存货 | 61,287,392.31 | 61,751,342.84 | 57,751,030.62 | 55,008,874.54 |
| 其他流动资产 | 2,403,614.28 | 1,379,700.36 | 11,238,433.34 | 4,972,944.33 |
| 流动资产合计 | 653,790,531.4 | 690,938,518.62 | 678,355,838.27 | 691,774,180.51 |
| 非流动资产: | | | | |
| 固定资产 | 38,573,319.65 | 39,502,967 | 29,844,251.25 | 29,045,175.02 |
| 在建工程 | 5,827,904.78 | 2,661,729.7 | 21,061,557.84 | 12,717,404.34 |
| 使用权资产 | 15,018,066.95 | 16,209,193.38 | 18,012,035.54 | 18,837,832.91 |
| 无形资产 | 53,377,285.37 | 54,234,958.4 | 56,227,999 | 55,581,246.07 |
| 商誉 | 1,020,272,123.92 | 1,019,645,700.98 | 1,019,645,700.98 | 1,005,705,419.88 |
| 长期待摊费用 | 16,248,992.25 | 16,850,876.22 | 6,901,476.52 | 5,918,029.95 |
| 递延所得税资产 | 115,205.25 | 732,845.71 | 734,688.06 | 736,020.86 |
| 其他非流动资产 | - | 2,539,000 | 2,539,000 | 6,523,910 |
| 非流动资产合计 | 1,149,432,898.17 | 1,152,377,271.39 | 1,154,966,709.19 | 1,135,065,039.03 |
| 资产总计 | 1,803,223,429.57 | 1,843,315,790.01 | 1,833,322,547.46 | 1,826,839,219.54 |
| 流动负债: | | | | |
| 短期借款 | 3,000,000 | - | - | - |
| 应付票据及应付账款 | 8,838,838.1 | 10,776,717.14 | 9,634,642.13 | 8,795,466.25 |
| 应付账款 | 8,838,838.1 | 10,776,717.14 | 9,634,642.13 | 8,795,466.25 |
| 合同负债 | 10,251,730.66 | 7,152,182.87 | 10,346,048.79 | 9,808,394.05 |
| 应付职工薪酬 | 10,605,192.29 | 14,083,197.7 | 12,944,408.34 | 17,897,696.21 |
| 应交税费 | 6,377,292.27 | 6,674,905.36 | 6,976,093.44 | 11,811,318.93 |
| 其他应付款合计 | 42,555,165.11 | 38,353,699.75 | 39,943,918.84 | 48,269,483.41 |
| 一年内到期的非流动负债 | 3,983,431.33 | 3,039,862.41 | 2,602,841.5 | 3,660,562.74 |
| 其他流动负债 | 44,644.59 | 41,492.85 | 21,663.27 | 3,537.75 |
| 流动负债合计 | 85,656,294.35 | 80,122,058.08 | 82,469,616.31 | 100,246,459.34 |
| 非流动负债: | | | | |
| 租赁负债 | 11,202,026.34 | 12,583,091.83 | 14,157,190.1 | 13,936,850.36 |
| 递延所得税负债 | 9,100,348.49 | 8,893,468.12 | 9,894,225.94 | 9,462,422.08 |
| 非流动负债合计 | 20,302,374.83 | 21,476,559.95 | 24,051,416.04 | 23,399,272.44 |
| 负债合计 | 105,958,669.18 | 101,598,618.03 | 106,521,032.35 | 123,645,731.78 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 655,662,200 | 655,662,200 | 655,662,200 | 657,900,000 |
| 资本公积 | 277,874,621.44 | 276,383,135.19 | 279,135,088.74 | 281,859,046.69 |
| 减:库存股 | 31,750,562.25 | 31,750,562.25 | 31,750,562.25 | 42,383,021.39 |
| 盈余公积 | 108,213,650.13 | 108,213,650.13 | 107,480,336.81 | 106,390,165.3 |
| 未分配利润 | 523,899,964.25 | 573,123,555.67 | 566,523,735.75 | 556,712,192.16 |
| 归属于母公司股东权益合计 | 1,533,899,873.57 | 1,581,631,978.74 | 1,577,050,799.05 | 1,560,478,382.76 |
| 少数股东权益 | 163,364,886.82 | 160,085,193.24 | 149,750,716.06 | 142,715,105 |
| 股东权益合计 | 1,697,264,760.39 | 1,741,717,171.98 | 1,726,801,515.11 | 1,703,193,487.76 |
| 负债和股东权益合计 | 1,803,223,429.57 | 1,843,315,790.01 | 1,833,322,547.46 | 1,826,839,219.54 |
| 公告日期 | 2025-10-30 | 2025-08-28 | 2025-04-22 | 2025-04-22 |
| 审计意见(境内) | | | | 标准无保留意见 |